Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rab-12 (RAB12) is a small GTPase enzyme belonging to the Ras superfamily, centrally involved in the regulation of intracellular membrane trafficking, including endocytic recycling, endosome to lysosome transport, and autophagy[2][5][6][9]. RAB12 cycles between inactive GDP-bound and active GTP-bound states, recruiting effectors that mediate vesicle formation, movement, and fusion[6]. Its phosphorylation by LRRK2 is particularly relevant in the brain and has been implicated in the pathogenesis of Parkinson's disease, where it regulates primary ciliogenesis and centrosome homeostasis in astrocytes[4][8]. RAB12 also participates in clathrin-independent endocytosis and the trafficking of cell surface receptors such as EGFR[2]. Dysfunction of Rab12 activity, such as defective prenylation or aberrant kinase regulation, leads to impaired autophagic flux and may contribute to neurodegenerative and other diseases[2][4][6].
Drugs targeting LRRK2 may inhibit Rab12 phosphorylation and downstream cilia/centrosome defects; modulation of autophagy via Rab12 activity (no direct Rab12-targeting drugs presently clinically available)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rab-12 (RAB12).